New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;PFE;DUF;CG;HLF;CALM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
May 6, 2015
17:03 EDTHLFOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
14:01 EDTHLFHerbalife jumps after earnings, accuses Ackman of manipulation in related filing
Shares of Herbalife (HLF) are sharply higher after the company reported better than expected earnings and increased its projection for fiscal year profits. In a regulatory filing associated with the earnings report, Herbalife appeared to accuse billionaire investor Bill Ackman of "manipulative activity" and suggested that a number of government agencies, including the Department of Justice, had begun investigating him. Ackman has had a large short interest in Herbalife since 2012 and he has repeatedly accused the company of operating a pyramid scheme. WHAT'S NEW: "Since late 2012, a short seller has made and continues to make allegations regarding the company and its network marketing program," Herbalife stated in an SEC filing that was disclosed last night. The statement appears to refer to Ackman, since he began shorting Herbalife's stock in late 2012. Herbalife wrote that the allegations "are without merit," and noted that it has contacted government officials about what it believes are efforts to manipulate its stock. Herbalife then appeared to suggest that various government agencies were probing its allegations about the short seller. "Because of these allegations, the company and others have received and may receive additional regulatory and governmental inquiries. For example, the company has previously disclosed inquiries from the Federal Trade Commission, Securities and Exchange Commission and other governmental authorities," Herbalife stated in its regulatory filing. In March, Bloomberg reported that the FBI was probing one of Ackman's outside consultants. WHAT'S NOTABLE: Herbalife last night reported stronger than expected results and raised its 2015 profit guidance. The company said it is "confident that it is building a stable foundation for volume and sales growth." PRICE ACTION: In midafternoon trading, Herbalife surged 20% to $48 per share.
10:03 EDTBMYBristol-Myers says follow-up data show Nulojix demonstrates death risk reduction
Subscribe for More Information
09:36 EDTHLFActive equity options trading on open
Active equity options trading on open: AAPL FB BAC HLF EA GRPN EXPD DIS BABA
09:23 EDTHLFHerbalife gaps up and runs higher in pre-market trading following earnings
The company boosted its outlook when it reported results last night after the close. Shares are trading up over 14%, with price last at $45.78. At that level next resistance is at $47.79. Support is at $43.20.
09:16 EDTHLFOn The Fly: Pre-market Movers
Subscribe for More Information
08:57 EDTPFEGlaxoSmithKline return of transaction net proceeds to be reduced to GBP1B
Subscribe for More Information
07:49 EDTHLFHerbalife valuation overly discounts cash flow and business, says Canaccord
Canaccord said the current valuation of Herbalife overly discounts its business and cash flow. The firm noted its Q1 results beat expectations, citing its business trends and margins as well as the changes to its marketing plan. Canaccord reiterated its Buy rating and raised its price target to $53 from $50 on Herbalife shares.
07:22 EDTBMYDeutsche Bank to hold a conference
40th Annual Health Care Conference is being held in Boston on May 6-7 with webcasted company presentations to begin on May 6 at 8 am; not all company presentations may be webcasted. Webcast Link
05:48 EDTPFEViiV Healthcare begins Phase III trial with dolutegravir/rilpivirine combination
Subscribe for More Information
May 5, 2015
18:45 EDTHLFOn The Fly: After Hours Movers
Subscribe for More Information
16:15 EDTHLFHerbalife rallies 11% to $44.44 following Q1 results
16:15 EDTHLFHerbalife says Q1 net income hurt by devaluation of Bolivar
Herbalife said A1 reported net income was negatively impacted by $36.3M in pre-tax charges, or 30c per diluted share after tax, related to the devaluation of the Venezuelan Bolivar. During the first quarter, the company remeasured its Bolivar-denominated monetary assets and liabilities at the SIMADI rate.
16:14 EDTHLFHerbalife says confident in bulding 'stable foundation'
Subscribe for More Information
16:13 EDTHLFHerbalife raises 2015 adjusted EPS outlook to $4.30-$4.60, consensus $4.22
Subscribe for More Information
16:12 EDTHLFHerbalife sees Q2 adjusted EPS $1.05-$1.15 , consensus $1.06
Sees Q2 Volume Point Growth vs. 2014 down 7.5% to down 4.5%, and net sales growth vs. 2014 down 13.5% to down 10.5%.
16:11 EDTHLFHerbalife reports Q1 adjusted EPS $1.29, consensus $1.01
Reports Q1 revenue $1.11B, consensus $1.09B.
16:01 EDTPFEOptions Update; May 5, 2015
iPath S&P 500 VIX Short-Term Futures up 64c to 21.45. Option volume leaders: AAPL TSLA TWTR FB BAC BABA GILD PFE CHK PBR C according to Track Data.
15:02 EDTHLFNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Mylan (MYL), consensus 69c... Devon Energy (DVN), consensus 26c... Pioneer Natural Resources (PXD), consensus 8c... CenturyLink (CTL), consensus 59c... Plains All American Pipeline (PAA), consensus 54c... Fiserv (FISV), consensus 86c... Electronic Arts (EA), consensus 25c... Plains GP Holdings (PAGP), consensus 14c... Agrium (AGU), consensus 34c... ONEOK (OKE), consensus 36c... Western Gas Partners (WES), consensus 44c... Digital Realty Trust (DLR), consensus $1.23... Newfield Exploration (NFX), consensus 8c... Community Health Systems (CYH), consensus 66c... SolarCity (SCTY), consensus (1.58)... Qiagen (QGEN), consensus 22c... Zillow (Z), consensus (11c)... Groupon (GRPN), consensus 1c... RenaissanceRe Holdings (RNR), consensus $2.43... Gulfport Energy (GPOR), consensus (9c)... SM Energy (SM), consensus 31c... Herbalife (HLF), consensus $1.01... Kinross Gold (KGC), consensus 0c... Myriad Genetics (MYGN), consensus 39c... Delek US (DK), consensus 10c... IAMGOLD (IAG), consensus (4c)... Halcón Resources (HK), consensus (2c).
09:17 EDTCGCarlyle Group 650K share Block Trade priced at $31.25
Subscribe for More Information
09:07 EDTBMYUBS healthcare and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:11 EDTHLFHerbalife May volatility elevated into Q1 and outlook
Subscribe for More Information
May 4, 2015
12:33 EDTHLFAckman says Herbalife business is deteriorating
Subscribe for More Information
09:35 EDTPFEActive equity options trading on open
Subscribe for More Information
07:35 EDTBMY, PFENewYorkBio to hold a conference
Subscribe for More Information
07:26 EDTBMY, PFEWorldwide Business Research to hold a conference
BioNetwork East 2015 Partnering Conference is being held in Miami on May 4-6.
07:23 EDTBMYAmerican Association of Neurological Surgeons to hold annual meeting
Subscribe for More Information
May 3, 2015
20:04 EDTCGTesco rejects offer by Carlyle Group for South Korean assets, Sunday Times says
Subscribe for More Information
May 1, 2015
16:02 EDTPFEOn The Fly: Morning Wrap-Up for May 1
Subscribe for More Information
15:43 EDTHLFHerbalife May volatility elevated into Q1 and outlook
Subscribe for More Information
10:03 EDTHLFHerbalife products stockpiled in Mexico, Seeking Alpha contributor says
Subscribe for More Information
07:43 EDTBMY, PFEExpensive drugs drove over 25% of 2013 Medicare drug spending, WSJ says
Subscribe for More Information
April 30, 2015
10:34 EDTPFEPfizer 'mystery bidder' for Swedish Orphan Biovitrum, Reuters says
Subscribe for More Information
09:36 EDTBMYBayer says Xarelto not losing market share to Eliquis, Reuters reports
Bayer (BAYRY) says Xarelto is not losing its U.S. market share to Bristol-Myers' (BMY) Eliquis, reports Reuters. In a conference call, Bayer said that Eliquis was taking business from warfarin and other drugs, but not from Xarelto. Reference Link
April 29, 2015
17:09 EDTBMYBristol-Myers announces FDA acceptance for sBLA for Opdivo
Subscribe for More Information
10:39 EDTPFE, BMYCiti analyst says outlook still strong for big pharma
Subscribe for More Information
10:00 EDTPFEOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Capital Agency (AGNC) downgraded at UBS... American Public Education (APEI) downgraded to Hold from Buy at Deutsche Bank... Annaly Capital (NLY) downgraded at UBS... C.H. Robinson (CHRW) downgraded to Neutral from Buy at BofA/Merrill... Church & Dwight (CHD) downgraded to Perform from Outperform at Oppenheimer... Cobalt (CIE) downgraded to Hold from Accumulate at Tudor Pickering... Compass Minerals (CMP) downgraded to Neutral from Overweight at JPMorgan... Corning (GLW) downgraded to Sell from Underperform at CLSA... Corporate Office Properties (OFC) downgraded at Stifel... Entergy (ETR) downgraded to Market Perform from Outperform at BMO Capital... First Interstate (FIBK) downgraded to Market Perform from Outperform at Wells Fargo... German American Bancorp (GABC) downgraded to Market Perform at Keefe Bruyette... IGI Laboratories (IG) downgraded to Market Perform from Outperform at Avondale... Lumber Liquidators (LL) downgraded at Longbow... Marvell (MRVL) downgraded at JMP Securities... National Oilwell (NOV) downgraded to Underweight from Equal Weight at Morgan Stanley... Oceaneering (OII) downgraded to Neutral from Buy at Sterne Agee CRT... OpenText (OTEX) downgraded to Sector Performer from Outperformer at CIBC... Parker-Hannifin (PH) downgraded on macro headwinds at Stifel... Pfizer (PFE) downgraded to Neutral from Buy at Citigroup... Procter & Gamble (PG) downgraded to Hold from Buy at Societe Generale... RTI International (RTI) downgraded to Market Perform from Outperform at FBR Capital... Ryder (R) downgraded to Neutral from Buy at Goldman... Stratasys (SSYS) downgraded to Neutral from Buy at Goldman... Targa Resources (TRGP) downgraded to Accumulate from Buy at Global Hunter... Total System (TSS) downgraded to Market Perform from Outperform at Wells Fargo... Twitter (TWTR) downgraded to Equal Weight from Overweight at Barclays... Wynn Resorts (WYNN) downgraded to Neutral at Susquehanna.
06:48 EDTCGCarlyle Group reports Q1 net income 54c, consensus 70c
Subscribe for More Information
06:46 EDTCGCarlyle Group continues to see accelerating level of investor interest
Subscribe for More Information
06:26 EDTBMYBristol-Myers price target raised to $80 from $60 at Citigroup
Citigroup raised its price target for Bristol-Myers to $80 while reiterating its positive on the Pharmaceuticals sector. Citi says it remains positive on the sector despite three years of outperformance. The firm believes biosimilars and transformative efficacy should facilitate "continued reimbursement for novel premium priced therapies." It keeps a Buy rating on Bristol-Myers.
06:16 EDTPFE, BMYPfizer downgraded to Neutral from Buy at Citigroup
Citigroup analyst Andrew Baum downgraded Pfizer (PFE) to Neutral citing the stock's "strong" relative outperformance this year. Buam prefers prefer Eli Lilly (LLY), which he upgraded this morning to Buy, and Bristol-Myers (BMY) among large-cap U.S. Pharmaceuticals. He keeps a $37 price target for Pfizer shares.
06:05 EDTBMYBristol-Myers reports positive results in Hepatitis C candidate daclatasvir
Subscribe for More Information
April 28, 2015
12:30 EDTPFE, BMYOn The Fly: Top stock stories at midday
Stocks on Wall Street were higher at midday after crossing back and forth across the flat line during morning trading, much like Apple (AAPL) shares, which were searching for direction despite the company's report last night having topped expectations on several measures, including revenue, profits, iPhone unit sales and capital return plans. ECONOMIC EVENTS: In the U.S., the Case Shiller 20-city home price index rebounded 0.93% on a seasonally adjusted basis in February, versus expectations for it to be up 0.7% on a month-over-month basis. The Conference Board's consumer confidence index dropped 6.2 points to 95.2 in April, versus expectations for it to have risen to 102.2. The Richmond Fed manufacturing index rose to -3 in April, versus expectations for a reading of -2. COMPANY NEWS: Shares of Apple were little changed near noon after the company last night reported March quarter earnings and sales well above expectations and boosted its shares buyback program to $140B from $90B and quarterly dividend by 11% to 52c. FBR Capital called the quarter “Picasso-like,” while Brian White at Cantor Fitzgerald upped his price target on shares to $195. Less sanguine are analysts at Pacific Crest, Maxim and Deutsche Bank. Noted investor Carl Icahn said afterward that Apple is "still undervalued and misunderstood" and promised to put out another in-depth report on the company within two weeks... IBM (IBM) approved an 18% increase in its quarterly dividend to $1.30 per common share. MAJOR MOVERS: Among the notable gainers was Dow member Merck (MRK), which advanced 5% after its Q1 sales and EPS beat expectations. Two other big name, big revenue drugmakers slid after their earnings reports, as Bristol-Myers (BMY) declined 1% and Pfizer (PFE) fell 0.5%. Also lower following its earnings report was The Container Store (TCS), which declined about 16% after its results and outlook missed expectations. INDEXES: Near midday, the Dow was up 49.61, or 0.28%, to 18,087.58, the Nasdaq was up 9.87, or 0.2%, to 5,070.12, and the S&P 500 was up 3.98, or 0.19%, to 2,112.90.
10:19 EDTHLFPershing Square lists Herbalife, Actavis as top Q1 losers
Subscribe for More Information
08:46 EDTBMYOn The Fly: Pre-market Movers
Subscribe for More Information
07:33 EDTPFEHospira will not provide annual projections given merger agreement with Pfizer
07:33 EDTPFEHospira expects merger agreement with Pfizer to be completed in 2H15
Subscribe for More Information
07:32 EDTBMYBristol-Myers narrows FY15 adjusted EPS view to $1.55-$1.70 from $1.60-$1.70
Consensus $1.72.
07:31 EDTBMYBristol-Myers reports Q1 EPS 71c, consensus 50c
Reports Q1 revenue $4.04B, consensus $3.8B.
07:12 EDTPFEPfizer lowers FY15 adjusted EPS view to $1.95-$2.05 from $2.00-$2.10
Consensus $2.07. Lowers FY15 revenue guidance to $44B-$46B from $44.5B-$46.5B, consensus $45.94B.
07:09 EDTPFEPfizer reports Q1 adjusted EPS 51c, consensus 49c
Subscribe for More Information
06:30 EDTCGCarlyle Group buys stake in Brazilian hospital chain, Reuters says
Subscribe for More Information
April 27, 2015
15:04 EDTBMY, PFENotable companies reporting before tomorrow's open
Subscribe for More Information
14:41 EDTPFEEarnings Watch: Pfizer up over 6% since its last earnings report
Subscribe for More Information
12:47 EDTPFEPfizer technical comments before earnings
Subscribe for More Information
09:03 EDTPFEChina Jo-Jo Drugstore signs incentive agreement with Pfizer subsidiary
China Jo-Jo Drugstores (CJJD) announced its subsidiary, Hangzhou Jiuzhou Grand Pharmacy Chain, has signed a new sales incentive agreement with Wyeth Pharmaceutical, a wholly owned subsidiary in China of Pfizer (PFE). The Agreement illustrated specific approaches and conditions of Jiuzhou Pharmacy's collaboration with Wyeth, including sales targets, promotional incentive to consumers, products and pricing methods. In return, Wyeth will fully support Jiuzhou Pharmacy with priority delivery, favorable purchase prices and promotional activities.
08:41 EDTPFETelegraph discusses potential takeover of GSK by Pfizer
Subscribe for More Information
08:19 EDTBMYBristol-Myers announces ALLY-1 trial met primary endpoints
Subscribe for More Information
06:19 EDTBMY, PFEPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
05:47 EDTHLFStocks with implied volatility movement; HLF ALTR
Subscribe for More Information
April 24, 2015
08:09 EDTBMYBristol-Myers May weekly volatility elevated into Q1 and outlook
Bristol-Myers May weekly call option implied volatility is at 27, May is at 21, June is at 22, September is at 22; compared to its 26-week average of 22 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on April 28.
07:47 EDTBMYBristol-Myers receives positive CHMP opinion in EU for Opdivo
Subscribe for More Information
06:59 EDTCALMTulane University to hold a conference
Subscribe for More Information
April 23, 2015
11:08 EDTHLFHerbalife confirms to Bloomberg 2% price increase in U.S.
Subscribe for More Information
07:41 EDTHLFHerbalife price target raised to $50 from $42 at Canaccord
Subscribe for More Information
April 22, 2015
07:28 EDTCALMMexico halts imports of poultry products from Iowa due to bird flu, Reuters says
Subscribe for More Information
07:07 EDTBMYEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use